Monday (29.10.2018)

07:30 – 09:00

Scientific Session Advanced Stages

  • ECHELON1 Update

  • HD18 Update

  • LYSA AHL2011 Phase III Study

09:15 – 10:15

Celgene GmbH Satellite Symposium Sponsored Session 6

10:30 – 12:00

Scientific Session Pediatric HL

  • PD1/-L1 Expression in Pediatric HL

  • Genotyping in Familial HL

  • Cost and Benefit of Targeted Therapies

12:15 – 13:45

Merck & Co, Inc. Satellite Symposium Sponsored Session 7

14:00 – 15:30

Scientific Session Immunotherapy – Clinical

  • Checkmate 205: Cohort D

  • GHSG NIVAHL Phase II Trial

15:30 – 16:00

Main Program Poster Walk

16:00 – 17:30

Scientific Session Relapsed/Refractory HL

  • Transplant BRaVE : Phase II trial

  • Novel Agents in First Line Salvage

17:30

Main Program Closing Remarks

ISHL11 Preliminary Program

ISHL11 Preliminary Program